Aspirin use and survival after the diagnosis of breast cancer: a population-based cohort study
about
Aspirin in the Treatment of Cancer: Reductions in Metastatic Spread and in Mortality: A Systematic Review and Meta-Analyses of Published StudiesBreast cancer survival among young women: a review of the role of modifiable lifestyle factorsCan Aspirin and Cancer Prevention be Ageless Companions?Dissecting the Dual Role of AMPK in Cancer: From Experimental to Human StudiesAspirin inhibits epithelial-to-mesenchymal transition and migration of oncogenic K-ras-expressing non-small cell lung carcinoma cells by down-regulating E-cadherin repressor Slug.Mutations in PIK3CA sensitize breast cancer cells to physiologic levels of aspirinCyclin A2 and CDK2 as Novel Targets of Aspirin and Salicylic Acid: A Potential Role in Cancer Prevention.Widespread parainflammation in human cancer.Prediagnosis aspirin use and outcomes in a prospective cohort of esophageal cancer patients.ADD-ASPIRIN: A phase III, double-blind, placebo controlled, randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non-metastatic solid tumoursSenescence and cancer: An evolving inflammatory paradox.Statistical methods for elimination of guarantee-time bias in cohort studies: a simulation study.Cancer Cell-Autonomous Parainflammation Mimics Immune Cell Infiltration.Senescence-associated IL-6 and IL-8 cytokines induce a self- and cross-reinforced senescence/inflammatory milieu strengthening tumorigenic capabilities in the MCF-7 breast cancer cell line.Antitumor and Antiangiogenic Effects of Aspirin-PC in Ovarian Cancer.Targeting Platelets for the Treatment of Cancer.Repurposing Drugs in Oncology (ReDO)-nitroglycerin as an anti-cancer agent.Prediagnostic aspirin use and mortality in women with stage I to III breast cancer: A cohort study in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.Low-dose Aspirin, Nonsteroidal Anti-inflammatory Drugs, Selective COX-2 Inhibitors and Breast Cancer Recurrence.Repurposing drugs in oncology (ReDO)-cimetidine as an anti-cancer agentSenescence-Inflammatory Regulation of Reparative Cellular Reprogramming in Aging and Cancer.Aspirin and nonsteroidal anti-inflammatory drugs after but not before diagnosis are associated with improved breast cancer survival: a meta-analysis.Concurrent new drug prescriptions and prognosis of early breast cancer: studies using the Danish Breast Cancer Group clinical database.Unlocking Aspirin's Chemopreventive Activity: Role of Irreversibly Inhibiting Platelet Cyclooxygenase-1.Celecoxib targets breast cancer stem cells by inhibiting the synthesis of prostaglandin E2 and down-regulating the Wnt pathway activity.Oxidant stress as a major determinant of platelet activation in invasive breast cancer.Antiplatelet Therapy in Breast Cancer Patients Using Hormonal Therapy: Myths, Evidence and Potentialities - Systematic ReviewSystematic review update of observational studies further supports aspirin role in cancer treatment: Time to share evidence and decision-making with patients?
P2860
Q26751511-28322EE6-E364-4EFD-BB52-6C01A0A48B99Q26766205-28FFBFD6-B602-4BE2-BA30-1E5B63BDB18CQ26827455-582B4575-6031-4759-B7AA-5BE1D40B23EAQ28081491-097B15FD-F8D8-4E13-A1E1-69AFF7475267Q35904508-DD16AE2D-BD67-48F8-81A8-B90A4FDE53BAQ36678527-30FFB36A-E601-445C-8300-A884842C3212Q36693257-0D92E710-7A51-4DA9-A31C-96DC6AACE38BQ37077058-4238BD8F-08B0-43FF-85A8-C6B2549974BEQ37361447-F99E00E3-E976-4A64-A4A2-82C66E9AC874Q37452750-1F4660E9-4074-46D3-A216-E24B7D9BCC7AQ38603571-B65D83B7-67D8-4FFD-817D-FDA3F89A385BQ38613762-E6CF1074-C8FC-4CD7-B3F8-E49C69F3E6E8Q38699338-7C94D184-5A76-4486-8293-752F0361AF05Q38704813-4B10D239-8DF6-4415-A916-BE5CA171946CQ38745843-46F18911-B352-4FDA-A183-A21FD072A6E8Q39454244-6216F1EB-DF58-4225-A27A-27FA017A6435Q40468319-D3E4EE04-A113-4DF3-BA85-DACA4004D42BQ40767715-1D89FFA2-514F-4A2A-8CFD-FFDF7E411936Q40836898-0D00E242-BD78-4FAE-BA74-F22E4D4C43F3Q41668110-FFB1EB72-20FE-4CDB-80D2-77BBC2FB76BDQ42121084-C8597504-52D8-44D7-884B-315D8E40067EQ44586148-EFD177DE-A9C0-4AE9-AFBC-4DC84E8FE61DQ47372688-34FA3624-9EB7-4E38-ACE3-64945863316FQ48009155-5CFB441C-7515-46BA-BB81-10E20184945FQ49271132-05CFA008-EA26-43FE-912F-127F677EF0E4Q51361563-D6A33B3C-9E15-460D-BFCF-735CE9EB468EQ57108351-2C9190F0-A555-4F1A-A3F2-81A75F41AE11Q58699234-2D6FDF46-4D71-4112-95E1-38E8C994756B
P2860
Aspirin use and survival after the diagnosis of breast cancer: a population-based cohort study
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Aspirin use and survival after ...... population-based cohort study
@ast
Aspirin use and survival after ...... population-based cohort study
@en
type
label
Aspirin use and survival after ...... population-based cohort study
@ast
Aspirin use and survival after ...... population-based cohort study
@en
prefLabel
Aspirin use and survival after ...... population-based cohort study
@ast
Aspirin use and survival after ...... population-based cohort study
@en
P2093
P2860
P356
P1476
Aspirin use and survival after ...... population-based cohort study
@en
P2093
A M Thompson
D M Fraser
P2860
P2888
P304
P356
10.1038/BJC.2014.264
P407
P577
2014-06-19T00:00:00Z
P5875
P6179
1021106207